Comar reinforces services to medical device OEMs with iMark Molding acquisition

Mergers and acquisitionsA supplier of rigid plastic packaging to the medical, food and beverage, and other sectors, Comar (Voorhees, NJ) announced today the acquisition of iMARK Molding, a custom contract manufacturer focused on serving the medical device industry. The combined company will offer additional best-in-class engineering and custom plastic molding and assembly services to Comar’s medical device, diagnostics and pharmaceuticals customers. The acquisition will support Comar’s growth objectives in the medical and pharmaceutical segments, the company said in a press release.

Based in Woodville, WI, near Minneapolis, iMARK specializes in complex scientific injection molding, automated and manual assembly, and cleanroom operations. The company’s 130,000-square-foot facility is certified to ISO 13485 and houses more than 30 injection molding presses and a 15,000-square-foot ISO Class 7 cleanroom. iMARK is a provider of custom injection molded diagnostic and surgical medical devices and has reaped numerous accolades including Wisconsin Manufacturer of the Year, Special Award for Enterprise Precision; St. Croix EDC Business of the Year; and an RJG Training Excellence award for its commitment to the RJG Master Molder certification program

Comar said that the acquisition will enhance its ability to serve medical device customers by bringing best-in-industry employees, additional cleanroom scientific injection molding capacity, engineering talent and quality precision measurement capabilities. No plant closures or employee layoffs are planned at Comar or iMARK as a result of this acquisition.

Founded in 1949, Comar is a designer and manufacturer of rigid plastic solutions. Comar has a longstanding reputation for developing creative, industry-compliant packaging and dispensing solutions for customers who count on them for quality-driven engineering and manufacturing. Comar is now better positioned with this acquisition and other recent investments to address the unmet needs of OEMs in Class 1 and 2 medical and healthcare consumables, which is experiencing favorable tailwinds from the adoption of disposables, an aging population and increased outsourcing, said the company in a press release.

Mark Sturtevant, President of iMARK, said, “Comar brings a unique set of capabilities that will better serve our customers—full service, in-house design, development and prototyping with IDWORKS, scale in procurement, a deeper engineering bench with a broad set of specializations, and multiple plants with capacity across the United States.” Sturtevant will continue to manage day-to-day operations of the iMARK facility and will be fully involved in efforts to serve current and future iMARK and Comar customers.

“We are so excited to be welcoming Mark and Linda Sturtevant and their outstanding team to the Comar organization,” said Comar CEO Mike Ruggieri. “Over the last 20 years, Mark and Linda have built a high-performance, customer-centric team with the best scientific injection molding capabilities we have seen across the industry. They truly know how to serve their customers with parts right the first time . . . and repeat that reliably. We look forward to partnering with them to better serve our current and prospective customers with new capacity and capabilities. And we look forward to continuing to acquire strategic and complementary businesses like iMARK,” said Ruggieri.

Comar operates nine manufacturing and distribution locations across the United States and employs a host of rigid plastic packaging technologies, including injection molding, injection blow molding, injection stretch blow molding and extrusion blow molding, which are complemented by a full suite of value-added service offerings. Comar’s principal owner is Morgan Stanley Capital Partners.

Image: Cacaroot/Adobe Stock

Comments (0)

Please log in or to post comments.
  • Oldest First
  • Newest First
Loading Comments...